Joshua Safer
@JoshuaSafer
Followers
388
Following
560
Media
18
Statuses
609
Joined March 2019
RT @TheAACE: This analysis aimed to assess whether gender-affirming hormone therapy and other potential risk factors are associated with VT….
endocrinepractice.org
The risk of venous thromboembolism (VTE) with feminizing gender-affirming hormone therapy is an area of concern. This analysis aimed to assess whether gender-affirming hormone therapy and other...
0
1
0
RT @TheEndoSociety: There is only one week left to apply for our two professional development programs, Future Leaders Advancing Research i….
endocrine.org
ExCEL provides clinical trainees with the resources needed to develop professional skills and a network of colleagues and mentors that will help advance their careers.
0
2
0
RT @vtangpricha: November’s #EndocrinePractice by @JoshuaSafer and Dr Slack and others from @IcahnMountSinai Evaluating the Risk of Venous….
endocrinepractice.org
The risk of venous thromboembolism (VTE) with feminizing gender-affirming hormone therapy is an area of concern. This analysis aimed to assess whether gender-affirming hormone therapy and other...
0
2
0
RT @TransCareSinai: Cyproterone acetate (CPA) may not promote breast growth more than spironolactone when paired with estrogens in transgen….
academic.oup.com
Angus et al, in their article titled “Effect of Spironolactone and Cyproterone Acetate on Breast Growth in Transgender People: A Randomized Clinical Trial,
0
2
0
Cyproterone acetate (CPA) may not promote breast growth more than spironolactone when paired with estrogens in transgender women. Read why my @TransCareSinai @DOMSinaiNYC colleague Daniel Slack and I think this is another reason CPA is not preferred.
academic.oup.com
Angus et al, in their article titled “Effect of Spironolactone and Cyproterone Acetate on Breast Growth in Transgender People: A Randomized Clinical Trial,
0
1
3
RT @vtangpricha: In Press #EndocrinePractice by @JoshuaSafer @TransCareSinai et al Evaluating the Risk of Venous Thromboembolism in Transfe….
endocrinepractice.org
The risk of venous thromboembolism (VTE) with feminizing gender-affirming hormone therapy is an area of concern. This analysis aimed to assess whether gender-affirming hormone therapy and other...
0
2
0
Thank you #EndocrinePractice for featuring work by @TransCareSinai @IcahnMountSinai @DOMSinaiNYC @MountSinaiNYC Dr. Daniel Slack with me showing less blood clot risk in transgender women. Also presenting at #WPATH2024!.
In Press #EndocrinePractice by @JoshuaSafer @TransCareSinai et al Evaluating the Risk of Venous Thromboembolism in Transfeminine and Gender Diverse People: A Retrospective Analysis. Risks of thromboembolism much lower than previously thought #WPATH2024
0
1
5
RT @vtangpricha: Review by Rothman @DavidgePitts @JoshuaSafer and others The Use of Injectable Estradiol in Transgender and Gender Diverse….
endocrinepractice.org
Feminizing gender-affirming hormone therapy is the mainstay of treatment for many transgender and gender diverse people. Injectable estradiol preparations are recommended by the World Professional...
0
3
0
So excited to see our own @marcibdoc from @TransCareSinai opening the 2024 @wpath scientific conference in Portugal. We have 17 @MountSinaiNYC @IcahnMountSinai presentations and are looking to learn much from the 1300+ other attendees!.
0
2
5
RT @TransCareSinai: Great work by our @TransCareSinai @MountSinaiNYC @DOMSinaiNYC @IcahnMountSinai team led by Daniel Slack and @JoshuaSafe….
0
2
0
In transgender women, blood clot risk may not be connected to estrogen. It might be connected to health care access and other medical concerns. Read the @TransCareSinai @MountSinaiNYC @DOMSinaiNYC @IcahnMountSinai report by endocrinologist Daniel Slack:
1
13
47
RT @RoyZucker1: A groundbreaking training course for family physicians on transgender care. Three full days with top professionals, providi….
0
2
0
RT @DrUroRecon: Welcome to @MountsinaiUro Anne! So excited to have @SocietyGURS matched Anne Yin from @mcgillu #reconstructiveurology @Tra….
0
4
0
RT @TransCareSinai: Our executive director @JoshuaSafer is ending #Pride month in #Israel with @RoyZucker1 and Shimrit Arbel training prima….
0
2
0
A perfect activity for the end of #Pride month: joining Shimrit Arbel and @RoyZucker1 with experience from @TransCareSinai - training primary care providers here in #Israel to expand care for transgender and gender diverse people here.
A groundbreaking training course for family physicians on transgender care. Three full days with top professionals, providing exceptional exposure. @JoshuaSafer
1
1
4
RT @TransCareSinai: Our executive director @JoshuaSafer is in Israel joining in the training of primary care providers from across the co….
0
3
0
What a way to start the week. I’m here in Israel joining Roy Zucker and Shimrit Arbel at the start of their 3-day program training for about 25 primary care providers in gender affirming healthcare - a substantial effort to expand access for trans and gender diverse people here!
0
2
11
RT @joshuajosephmd: TY @EndocrineToday for highlighting @TheEndoSociety opening plenary:. “DM & Cardiometabolic Risk: From People to Popula….
healio.com
BOSTON — Lowering cardiovascular risk for people with type 2 diabetes requires effort from far beyond the clinician’s office, leveraging creative community partnerships that address social determin...
0
5
0
RT @NewFestNYC: Thank you to our @NewFestNYC Pride sponsor, @InstAdvancedMed! . For @MountSinaiNYC's Center for Transgender Medicine and Su….
0
5
0